Zhejiang Sunflower AGM approves 2024 reports and plans

Zhejiang Sunflower Great Health Liability Company [SZSE:300111] successfully held its 2024 Annual General Meeting of Shareholders, securing approval for all twelve proposed resolutions. Key approvals included the 2024 Board of Directors and Supervisory Board work reports, the 2024 annual financial statements, and the profit distribution plan. Shareholders also approved the 2024 annual report and its summary, the reappointment of the accounting firm for 2025, and a plan for 2025 forward foreign exchange lock-in. Additionally, resolutions regarding director and supervisor compensation, addressing accumulated losses, cash management, and applications for credit facilities were also passed. The meeting was attended by 220 shareholders and proxies, representing 372,074,120 shares, accounting for 28.9055% of the company's total voting shares. Shanghai AllBright Law Offices provided legal counsel, affirming the legitimacy and validity of the meeting's procedures and outcomes.